For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Contrast agents are chemicals, which are used to enhance the image effect to observe by injecting (or taking) into human tissue or organs. The density of contrast agents is higher or lower than surrounding tissue and this contrast can display images via some device.
Contrast agents are widely used in diagnostic imaging procedures such as CT scans, MRIs, X-rays, ultrasounds, and related procedures.
In terms of volume, the production of contrast agents was about 242794 K Dose in 2015 and is anticipated to reach 329523 K Dose by 2021.
The contrast agents industry is a quite concentrated market with a few companies dominates the market. Bayer is the dominate producer of contrast agents, the production was 74476 K Dose in 2015, accounting for about 30.67% of the total amount, followed by GE Healthcare, with the production market share of 25.54 %. The top four companies occupied about 79.40 % production share of the market in 2015.
At present, in the foreign industrial developed countries the contrast agents industry is generally at a more advanced level, the world's large enterprises are mainly concentrated in the North America
Europe and Japan, accounted for most of the international market share. Meanwhile, these companies have more advanced equipment, strong R&D capabilities; the technical level is in a leading position.
The emerging markets (such as China, India) have relatively small scales. However, they have much higher market increasing growth than developed countries. They are the main growth areas in the global contrast agents market.
The sales volume shares of North America, Europe, Japan, China, India and Southeast Asia were 27.91%, 19.65%, 22.52%, 11.07%, 7.35% and 3.52%.
There are mainly two types of contrast agents: iodine preparations type and gadolinium preparations type. Currently, iodine preparations type is the main product and it occupied 81 % share in 2015.
X-CT accounted for the largest market with about 85.10 % market share of the global contrast agents consumption in 2015. Moreover, it is anticipated to grow at a CAGR of 4.92 % from 2016 to 2021. With over 13 % share in the contrast agents market, MRI was the second largest application market in 2015, and is anticipated to grow at a CAGR of 5.71% in terms of consumption volume, from 2016 to 2021.
Under the influence of raw material, market competitions and economic conditions, the price of contrast agents was fluctuant in recent years. Over the next few years, we predict that price will decline. As competition intensifies, prices gap between different brands will go narrowing.
According to this study, over the next five years the Contrast Agents market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Contrast Agents business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Contrast Agents market by product type, application, key manufacturers and key regions and countries.
This study considers the Contrast Agents value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
- Iodine Preparations
- Gadolinium Preparations
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- - United States
- - Canada
- - Mexico
- - Brazil
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- - Germany
- - France
- - UK
- - Italy
- - Russia
- - Spain
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
- GE Healthcare
- Bracco Imaging
- Guerbet Group
- Hengrui Medicine
- BeiLu Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
- To study and analyze the global Contrast Agents consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
- To understand the structure of Contrast Agents market by identifying its various subsegments.
- Focuses on the key global Contrast Agents manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Contrast Agents with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Contrast Agents submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.